• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

能量供应在延迟后除极发生中的作用——对缺血或再灌注心律失常的影响

Proposed role of energy supply in the genesis of delayed afterdepolarizations--implications for ischemic or reperfusion arrhythmias.

作者信息

Coetzee W A, Opie L H, Saman S

机构信息

Department of Medicine, University of Cape Town, Observatory, South Africa.

出版信息

J Mol Cell Cardiol. 1987 Oct;19 Suppl 5:13-21. doi: 10.1016/s0022-2828(87)80606-5.

DOI:10.1016/s0022-2828(87)80606-5
PMID:2448488
Abstract

Delayed afterdepolarizations (DADs) are Ca++-dependent electrophysiological abnormalities, which are evoked by a variety of conditions that induce intracellular Ca++ overload, including fast pacing, isoproterenol, dibutyryl cyclic AMP, and intracellular injection of Ca++. Since Ca++ overload is suspected of playing a role in both ischemic and reperfusion cellular damage, a reasonable hypothesis would be that DADs could play a role in ischemic or reperfusion arrhythmias. No direct proof has, however, been obtained for such a role for DADs. We propose that DADs could be associated with arrhythmias in which there is Ca++ overload of sufficient magnitude to cause an increased oscillatory release of Ca++ from the sarcoplasmic reticulum (SR), provided energy is available in the form of ATP. A sustained increase of Ca++ is likely to reflect energy depletion and therefore exclude a significant contribution of DADs to arrhythmia development. Thus, DADs are more likely to play a role in: (i) reperfusion arrhythmias and (ii) arrhythmias arising in moderately ischemic tissue, than in severe ischemia with marked energy depletion.

摘要

延迟后除极(DADs)是依赖钙离子的电生理异常现象,由多种导致细胞内钙离子超载的情况诱发,包括快速起搏、异丙肾上腺素、二丁酰环磷腺苷以及细胞内注射钙离子。由于怀疑钙离子超载在缺血和再灌注细胞损伤中均起作用,一个合理的假设是DADs可能在缺血或再灌注心律失常中起作用。然而,尚未获得关于DADs起这种作用的直接证据。我们提出,只要有ATP形式的能量可用,DADs可能与心律失常相关,在这些心律失常中,存在足够程度的钙离子超载,导致肌浆网(SR)中钙离子的振荡释放增加。钙离子的持续增加可能反映能量耗竭,因此排除了DADs对心律失常发生的显著贡献。因此,与能量明显耗竭的严重缺血相比,DADs更有可能在以下情况中起作用:(i)再灌注心律失常和(ii)中度缺血组织中出现的心律失常。

相似文献

1
Proposed role of energy supply in the genesis of delayed afterdepolarizations--implications for ischemic or reperfusion arrhythmias.能量供应在延迟后除极发生中的作用——对缺血或再灌注心律失常的影响
J Mol Cell Cardiol. 1987 Oct;19 Suppl 5:13-21. doi: 10.1016/s0022-2828(87)80606-5.
2
Effects of components of ischemia and metabolic inhibition on delayed afterdepolarizations in guinea pig papillary muscle.缺血和代谢抑制成分对豚鼠乳头肌延迟后去极化的影响。
Circ Res. 1987 Aug;61(2):157-65. doi: 10.1161/01.res.61.2.157.
3
Inhibition by simulated ischemia or hypoxia of delayed afterdepolarizations provoked by cyclic AMP: significance for ischemic and reperfusion arrhythmias.模拟缺血或缺氧对环磷酸腺苷引发的延迟后去极化的抑制作用:对缺血性和再灌注性心律失常的意义。
J Mol Cell Cardiol. 1988 Feb;20(2):91-5. doi: 10.1016/s0022-2828(88)80022-1.
4
Sarcoplasmic reticulum Ca content, sarcolemmal Ca influx and the genesis of arrhythmias in isolated guinea-pig cardiomyocytes.豚鼠离体心肌细胞肌浆网钙含量、肌膜钙内流与心律失常的发生机制
J Mol Cell Cardiol. 2000 Feb;32(2):261-72. doi: 10.1006/jmcc.1999.1070.
5
Ryanodine and caffeine prevent ventricular arrhythmias during acute myocardial ischemia and reperfusion in rat heart.兰尼碱和咖啡因可预防大鼠心脏急性心肌缺血和再灌注期间的室性心律失常。
Circ Res. 1988 Feb;62(2):306-14. doi: 10.1161/01.res.62.2.306.
6
Clinical potential of sodium-calcium exchanger inhibitors as antiarrhythmic agents.钠钙交换体抑制剂作为抗心律失常药物的临床潜力。
Drugs. 2003;63(5):439-52. doi: 10.2165/00003495-200363050-00001.
7
The effect of inhibition of mitochondrial energy metabolism on the transient inward current of isolated guinea-pig ventricular myocytes.线粒体能量代谢抑制对分离的豚鼠心室肌细胞瞬时内向电流的影响。
J Mol Cell Cardiol. 1988 Mar;20(3):181-5. doi: 10.1016/s0022-2828(88)80051-8.
8
Delayed afterdepolarizations generate both triggers and a vulnerable substrate promoting reentry in cardiac tissue.延迟后除极既产生触发因素,又形成一个易损基质,促进心脏组织中的折返。
Heart Rhythm. 2015 Oct;12(10):2115-24. doi: 10.1016/j.hrthm.2015.06.019. Epub 2015 Jun 10.
9
Persistent increases in Ca(2+) influx through Cav1.2 shortens action potential and causes Ca(2+) overload-induced afterdepolarizations and arrhythmias.通过Cav1.2持续增加的钙离子内流会缩短动作电位,并导致钙离子过载引起的后去极化和心律失常。
Basic Res Cardiol. 2016 Jan;111(1):4. doi: 10.1007/s00395-015-0523-4. Epub 2015 Nov 26.
10
Mechanisms of ventricular arrhythmias in acute ischemia and reperfusion.急性缺血和再灌注时室性心律失常的机制
Cardiovasc Clin. 1992;22(1):3-18.

引用本文的文献

1
ArrhythmoGenoPharmacoTherapy.心律失常基因药物治疗
Front Pharmacol. 2020 May 12;11:616. doi: 10.3389/fphar.2020.00616. eCollection 2020.
2
Revisiting the ionic mechanisms of early afterdepolarizations in cardiomyocytes: predominant by Ca waves or Ca currents?重新探讨心肌细胞早期后除极的离子机制:主要由钙波还是钙电流引起?
Am J Physiol Heart Circ Physiol. 2012 Apr 15;302(8):H1636-44. doi: 10.1152/ajpheart.00742.2011. Epub 2012 Feb 3.
3
Effect of the angiotensin-converting enzyme inhibitor, perindoprilat, and of angiotensin-II on the transient inward current of rabbit ventricular myocytes.
Cardiovasc Drugs Ther. 1994 Aug;8(4):647-51. doi: 10.1007/BF00877418.
4
Role of calcium ions in reperfusion arrhythmias: relevance to pharmacologic intervention.钙离子在再灌注心律失常中的作用:与药物干预的相关性。
Cardiovasc Drugs Ther. 1988 Dec;2(5):623-36. doi: 10.1007/BF00054202.
5
KT-362 related effects on intracellular calcium release and associated clinical potential: arrhythmias, myocardial ischemia, and hypertension.KT - 362对细胞内钙释放的相关影响及相关临床潜力:心律失常、心肌缺血和高血压。
Cardiovasc Drugs Ther. 1990 Oct;4(5):1345-54. doi: 10.1007/BF02018262.
6
Calcium antagonists post-infarction: the significance of experimental studies on potentially lethal early ischemic ventricular arrhythmias.心肌梗死后的钙拮抗剂:关于潜在致命性早期缺血性室性心律失常实验研究的意义
Cardiovasc Drugs Ther. 1991 Aug;5(4):671-5. doi: 10.1007/BF03029739.
7
Should calcium antagonists be used after myocardial infarction? Ischemia selectivity versus vascular selectivity.心肌梗死后是否应使用钙拮抗剂?缺血选择性与血管选择性。
Cardiovasc Drugs Ther. 1992 Feb;6(1):19-24. doi: 10.1007/BF00050912.